Merrill Birkner, based in San Francisco, CA, US, is currently a Vice President, Portfolio Strategy and Analytics at Gilead Sciences, bringing experience from previous roles at 23andMe and Genentech. Merrill Birkner holds a 2001 - 2006 Ph.D. in Biostatistics @ University of California, Berkeley. With a robust skill set that includes Biostatistics, Drug Development, Clinical Development, Commercial Assessment, Valuation Modeling and more, Merrill Birkner contributes valuable insights to the industry. Merrill Birkner has 4 emails and 1 mobile phone number on RocketReach.